Targeted Therapy

253 molecules in this therapeutic area. Open any product for its details, or send an inquiry directly.

Connect With Us

Targeted Therapy (147)

Quick filters: Solid Tumour Hematologic Both Name A-Z Name Z-A

Therapeutic Areas

Sort by

Clear all filters

Molecule	Drug Class / Mechanism	Oncology Type
Prexasertib	DNA Damage Response Inhibitor (WEE1/ATR/CHK1)	Solid Tumour
Molecule Prexasertib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)
Pyrotinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Pyrotinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Rebastinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Rebastinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Refametinib	BRAF / MEK Inhibitor	Solid Tumour
Molecule Refametinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Regorafenib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Regorafenib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Relacorilant	Selective Glucocorticoid Receptor Antagonist (first-in-class)	Solid Tumour
Molecule Relacorilant Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Selective Glucocorticoid Receptor Antagonist (first-in-class)
Repotrectinib	ALK / ROS1 / NTRK Inhibitor	Solid Tumour
Molecule Repotrectinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Rezivertinib	EGFR / HER2 Tyrosine Kinase Inhibitor	Solid Tumour
Molecule Rezivertinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Ripretinib	Multi-Kinase / Anti-Angiogenic Inhibitor	Solid Tumour
Molecule Ripretinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Rogaratinib	FGFR Inhibitor	Solid Tumour
Molecule Rogaratinib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor
Roniciclib	CDK Inhibitor	Solid Tumour
Molecule Roniciclib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Rucaparib	PARP Inhibitor	Solid Tumour
Molecule Rucaparib Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor

Prexasertib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism DNA Damage Response Inhibitor (WEE1/ATR/CHK1)
Pyrotinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Rebastinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Refametinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism BRAF / MEK Inhibitor
Regorafenib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Relacorilant Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Selective Glucocorticoid Receptor Antagonist (first-in-class)
Repotrectinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism ALK / ROS1 / NTRK Inhibitor
Rezivertinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism EGFR / HER2 Tyrosine Kinase Inhibitor
Ripretinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism Multi-Kinase / Anti-Angiogenic Inhibitor
Rogaratinib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism FGFR Inhibitor
Roniciclib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism CDK Inhibitor
Rucaparib Targeted Therapy
Therapeutic Category Targeted Therapy Oncology Type Solid Tumour Drug Class / Mechanism PARP Inhibitor

‹ 1 … 7 8 9 10 11 … 13 ›

Product Range

Company

Global Network

Targeted Therapy

Targeted Therapy (147)

Prexasertib

Pyrotinib

Rebastinib

Refametinib

Regorafenib

Relacorilant

Repotrectinib

Rezivertinib

Ripretinib

Rogaratinib

Roniciclib

Rucaparib

Prexasertib

Pyrotinib

Rebastinib

Refametinib

Regorafenib

Relacorilant

Repotrectinib

Rezivertinib

Ripretinib

Rogaratinib

Roniciclib

Rucaparib